Revenue ($USD) : $746,641,000
R&D spend : $80,231,000
Employees : 1,634
Fiscal year end : 12/31/2023
CEO : Massimo Calafiore

www.orthofix.com

Orthofix’s 2023 merger with SeaSpine made it the world’s eighth-largest orthopedic device company, with sales growing quarter after quarter and revenue expected to come in around $800 million in 2024. The company’s under new leadership after ousting former CEO Keith Valentine, CFO John Bostjancic and Chief Legal Officer Patrick Keran in late 2023. –SW